Anzeige
Mehr »
Login
Sonntag, 05.05.2024 Börsentäglich über 12.000 News von 685 internationalen Medien
Cannabisaktien sollten nun den S&P um 60% outperformen!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
59 Leser
Artikel bewerten:
(0)

Global Pharmaceutical Traceability Market 2017-2021 - Growing Concern of Drug Counterfeit and Theft

DUBLIN, October 5, 2017 /PRNewswire/ --

The "Global Pharmaceutical Traceability Market 2017-2021" report has been added to Research and Markets' offering.

Research and Markets Logo

The global pharmaceutical traceability market to grow at a CAGR of 19.25% during the period 2017-2021.

Global Pharmaceutical Traceability Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

The latest trend gaining momentum in the market is Blockchain technology. Blockchain is a distributed ledger that records and stores information. The main features that make it unique are decentralization and immutability. Another feature is the authentication or verification of the product, before adding an information or giving access to information, the technology uniquely identifies the product.

According to the report, one of the major drivers for this market is Growing concern of drug counterfeit and theft. Counterfeit drugs are medicines that are manufactured in a fraudulent manner or can be mislabeled with different ingredients, source or other information. Illegal diversion of drugs is a major issue. Illegal diversion is the sales of drugs in countries apart from the ones where the drug is legally approved to be sold. Pharmaceutical theft can occur at any point in the supply chain, like manufacturer, wholesaler or distributor. Customers buy fake medicines either due to the lack of awareness or low price of such drugs.

Further, the report states that one of the major factors hindering the growth of this market is No global standard for serialization of drugs across the world. No global standards for serialization are adopted by the nations. Developing countries have come up with their own standards and regulations for serializing the drugs. Different countries follow different standards when serial numbers are assigned to the drug lots or batches.

Key vendors



  • Avery Dennison
  • Cognex
  • Datalogic
  • Impinj
  • Zebra Technologies

Other prominent vendors

  • Adents
  • Alien Technology
  • AlpVision
  • Atlantic Zeiser
  • Authentix
  • Axway
  • Bar Code Integrators
  • SATO VICINITY
  • SMARTRAC
  • TraceLink

Key Topics Covered:

Part 01: Executive Summary

Part 02: Scope Of The Report

Part 03: Research Methodology

Part 04: Introduction

Part 05: Market Segmentation By Technology

Part 06: Geographical Segmentation

Part 07: Decision Framework

Part 08: Drivers And Challenges

Part 09: Market Trends

Part 10: Vendor Landscape

For more information about this report visit https://www.researchandmarkets.com/research/5xk4cq/global


Media Contact:


Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716



Lithium vs. Palladium - Zwei Rohstoff-Chancen traden
In diesem kostenfreien PDF-Report zeigt Experte Carsten Stork interessante Hintergründe zu den beiden Rohstoffen inkl. . Zudem gibt er Ihnen konkrete Produkte zum Nachhandeln an die Hand, inkl. WKNs.
Hier klicken
© 2017 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.